Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creon Efficacy in Children with Cystic Fibrosis and PEI
NCT00690820Phase 3Completed
- Sponsor
- Solvay
- Start
- Jun 2008
- Primary completion
- Dec 2008
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of pancrelipase in pancreatic exocrine insufficiency (EPI), sponsored by Solvay. Started Jun 2008; status: completed.
02
Drugs
pancrelipase
03
Conditions
pancreatic exocrine insufficiency (EPI)
Beyond the preview
Go deeper on NCT00690820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00690820.